Key Takeaways

Over the past year, RKLB stock has surged 43.7%, significantly outperforming peers in the aerospace sector.

ARK Investment Management, led by Cathie Wood, accumulated more than 705,000 shares of RKLB valued at approximately $44 million across two recent trading sessions.

CEO Peter Beck said the year-end launch window for Neutron is “narrowing,” making it both a critical opportunity and a significant risk factor.

Blue Origin won a $700 million NASA contract for Mars communications infrastructure, dealing a setback to Rocket Lab’s competitive position.

The company’s contract backlog reached a record $2.36 billion, up 137% year over year, providing solid revenue visibility.

Shares of Rocket Lab (RKLB) are trading around $62.54, after falling 2.2% on Tuesday and sliding more than 50% from the peak reached in May. Even so, ARK Investment Management has continued to buy aggressively, adding 705,102 shares over two recent trading sessions for a total value of about $44 million.

Rocket Lab USA, Inc., RKLB

On Tuesday alone, ARK bought 504,799 shares across three separate ETFs, worth roughly $31.6 million based on Tuesday’s closing price.

The buying came amid persistent selling pressure, with RKLB declining in nine of the last 10 trading sessions before extending losses in after-hours trading. For investors, that contrast highlights a familiar setup in high-growth aerospace names: enthusiasm can remain strong around long-duration opportunities even as near-term execution risks and contract headlines keep volatility elevated.

Analyst sentiment remains constructive despite several price target revisions. On August 31, Bank of America analyst Ronald Epstein cut his price target from $115 to $110, mainly to reflect expected share dilution, while reiterating a Buy rating. Even after the reduction, Tuesday’s close implied upside of about 76%.

Following Rocket Lab’s second-quarter earnings report, Cantor Fitzgerald analyst Andres Sheppard raised his price target from $96 to $122, calling Neutron “the most material catalyst.” Roth Capital’s Suji Desilva lowered his target from $130 to $110 while keeping a Buy rating, saying the company’s large backlog provides “meaningful near-term revenue coverage.”

The Neutron Factor

Rocket Lab’s Neutron launch vehicle remains the center of investor debate. The rocket is intended to enter the medium-lift launch market, broadening the company’s addressable market well beyond Electron’s small-satellite niche.

However, CEO Peter Beck warned during the Q2 earnings call that the timeline for an inaugural launch before year-end is “narrowing.” Several critical tests still need to be completed successfully before flight operations can begin. Any further delay to Neutron would push back the growth path that underpins bullish analyst price targets.

The orbital launch market continues to face supply constraints, which could favor Rocket Lab if execution stays on schedule. Electron has completed 87 missions to date, while HASTE supports government programs. The company currently has commitments for more than 90 launches across Electron, HASTE, and Neutron.

NASA Contract Loss and Backlog Strength

Market sentiment took another hit in after-hours trading Tuesday after NASA announced Blue Origin as the winner of its Mars Telecommunications Network contract. The firm-fixed-price agreement has a potential value of $700 million, and Blue Origin is responsible for deploying a Mars orbiter by late 2028. Rocket Lab had been among the eligible bidders.

Even with that disappointment, Rocket Lab’s Q2 2026 backlog reached a record $2.36 billion, up 137% from the prior year. About 45.5% of that contracted work is scheduled to be recognized as revenue within the next 12 months, giving the market a clearer view of near-term business activity even as one bid result went against the company.

Recent strategic acquisitions of Mynaric and Motiv have expanded Rocket Lab’s capabilities in optical communications and robotics technologies. In August 2026, the company also won a place on the U.S. Space Force’s NITE-STAR IDIQ program, a contracting vehicle with a $981 million ceiling covering both space-based and ground systems.

Wall Street’s consensus earnings per share estimate for RKLB in 2026 has risen 44.44% over the past 60 days. Rocket Lab’s total debt-to-capital ratio stands at 0.83%, well below the industry benchmark of 61.47%. Its current ratio is 5.48, compared with the industry average of 2.06.

RKLB currently trades at 31.3 times forward price-to-sales, a substantial premium to the industry average of 7.64 times.